Based on previous finding that Nrf2 directly regulates CBR1 transcription via the upstream ARE region (Miura et al., 2013), we propose that CBR1 might be a potential therapeutic target for reducing MetS in the adult offspring under the control of Nrf2. Here, NFE2L2 is linked to metabolic syndrome.